Synthetic peptide corresponding to a region within residues 250 and 300 of human PGC1 alpha (SwissProt entry Q9UBK2).
This product may be covered by one or more of the following U.S. Patents.
Our Abpromise guarantee covers the use of ab84139 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/100 - 1/500.|
|IF||1/50 - 1/500.|
ab84139 has not yet been referenced specifically in any publications.